Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by StevenBirchon Jan 26, 2024 2:54pm
215 Views
Post# 35847647

RE:Theralase is making personalized cancer treatment a reality

RE:Theralase is making personalized cancer treatment a reality Eog another great article, you may have set a record for likes with 22 so far, well done.

So I see Roger say that BTD would be nice but not a must have and then talking about a marketing approval in 2026, that is a long way off. He does then go on to say that Pre-BTD and BTD are on schedule for Q1 and Q2 so I think the earlier comment was him being overly conservative after what has happened in the past. 

Also I don't see them doing $1M PPs every couple of months for the next 2-3 years so I think the highlighted comment is more what they expect. Also, they have plans to commence a PhaseI/II study for GBM, that would take money so there must be some irons in the fire. 
<< Previous
Bullboard Posts
Next >>